We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

MedCision Announces the ThawSTAR Early Adopter Program

Product News   Apr 07, 2017 | Original story from MedCision

 
MedCision Announces the ThawSTAR Early Adopter Program

Credit: MedCision

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

FairJourney Biologics enters antibody discovery agreement with Pandion Therapeutics

Product News

FairJourney Biologics S.A (FJB) and IONTAS Limited (IONTAS) today announced they have signed an agreement to discover antibodies with Pandion Therapeutics (Pandion).

READ MORE

BioVersys Announces First Subjects Dosed in Phase 1 Clinical Trial of BV100

Product News

BioVersys has reached a major milestone by entering clinical development with the start of Phase 1 testing of BV100 in healthy volunteers.

READ MORE

Abcam’s New Premium-Grade Bioactive Proteins, for Drug Discovery, Development and Manufacturing

Product News

Abcam’s new premium-grade proteins are manufactured in mammalian cell lines under animal-free conditions limiting endotoxins to ultra-low levels (< 5 EU/mg).

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE